TITLE

LILLY'S TERIPARATIDE GETS POSITIVE OPINION FROM CPMP

PUB. DATE
February 2003
SOURCE
Worldwide Biotech;Feb2003, Vol. 15 Issue 2, p8
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the positive opinion issued by the European Committee for Proprietary Medicinal Products concerning the teriparatide (rDNA origin) injection from Lilly.
ACCESSION #
9014647

 

Related Articles

  • Eli Lilly and Co.  // Indianapolis Business Journal;3/24/2003, Vol. 24 Issue 2, p35 

    Features Eli Lilly and Co., an Indianapolis, Indiana-based pharmaceutical company. Stock value; Major shareholders; Executive compensation; Corporate directors.

  • Lilly looms larger. Jefferson, Greg // Indianapolis Business Journal;07/19/99, Vol. 20 Issue 18, p1A 

    Reports on Indianapolis, Indiana-based drug firm Eli Lilly's expansion plan in Indiana. Company profile; Effect on the cultural and economic makeup of Indiana; Pledge of investments for construction and renovation projects; Projects; Addition of employees. INSET: In first speech to Indy...

  • Lilly banks on R&D. Jefferson, Greg // Indianapolis Business Journal;07/26/99, Vol. 20 Issue 19, p1 

    Reports on Eli Lilly and Co.'s plan to invest $1 billion into its pharmaceutical operations in Indianapolis, Indiana. Recruitment of researchers, computer specialists and technicians; Construction of new facilities.

  • Lilly.  // Formulary;Oct2000 Resource Guide, Vol. 35 Issue 10, p54 

    Features the Lilly & Co., a pharmaceutical manufacturer. Therapeutic areas targeted by its research and development; Signature product; Pharmaceutical products that have received approval from the United States Food and Drug Administration.

  • Lilly racing drugs to market. Ellison, Evelyn // Indianapolis Business Journal;04/28/97, Vol. 18 Issue 6, p1A 

    Reports on the pharmaceutical firm Eli Lilly & Co.'s plan to improve sales through its `Speed to Market' initiative. Leadership of company chairman Randall Tobias; Competition in the pharmaceutical industry; Drugs included in the company initiative; Ethical and legal issues involved; Company...

  • Eli Lilly and Co.  // Indianapolis Business Journal;02/16/98, Vol. 18 Issue 49, p46 

    Profiles Indianapolis, Indiana-based pharmaceutical company Eli Lilly and Co. Value of the company's stocks; Common shares; Executive compensation; Directors.

  • Eli Lilly among drug-makers joining pharmacy settlement.  // Indianapolis Business Journal;2/5/96, Vol. 16 Issue 47, p44A 

    Reports that Eli Lilly & Co. has joined 13 other pharmaceutical companies in a proposed settlement of a lawsuit filed by pharmacists. Charges against the companies; Estimated value of the settlement.

  • Here's a novel way of looking at the drug business. Hetrick, Bruce // Indianapolis Business Journal;10/14/2002, Vol. 23 Issue 31, p74 

    Presents a fictitious story critical of a drug-dilution fiasco involving Eli Lilly & Co. Analogy between the book publishing business and the drug industry.

  • Eli Lilly to disclose financial ties to doctors, a drug industry first. Young, Jeffrey // Hill;9/24/2008, Vol. 15 Issue 110, p22 

    The article reports on the plans of the drug maker Eli Lilly & Co. to create a public database that lists the names of physicians' pay for its engagements and consulting services.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics